Bulent Mutus funded by Astra Zeneca...
Dr. Bulent Mutus has received a contract from AstraZeneca to explore the effects of a new antiplatelet drug on plasma membrane cholesterol raft-ADP receptor interactions.
Click here for more information on his research program.
New NMR manager, and new website...Dr. Matthew Revington, our new NMR manager, has launched our new departmental NMR Facility website. Click here to visit the website, or cut and paste the following link into your browser:
http://www.uwindsor.ca/nmr
Marlys Koschinsky and Michael Boffa join the department...This past summer, two new faculty members with expertise in Biochemistry joined the Department of Chemistry & Biochemistry: - Marlys Koschinsky has come to the University of Windsor from Queens University as the new Dean of Science, and will be heading up a research program focusing on the use of molecular biology, protein chemistry, cell biology, and proteomic techniques for the study of the relationships between structure and function in the apolipoprotein apo(a).
- Michael Boffa also joins us from Queens' University. His research focuses on the protein TAFI (thrombin-activatable fibrinolysis inhibitor) and its function as a novel mediator of the balance between coagulation and fibrinolysis.
Welcome to the department!
